A61K 39 - Medicinal preparations containing antigens or antibodies

Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
10/2006
10/12/2006	US20060228348 Targeting of glycoprotein therapeutics
10/12/2006	US20060228342 Method for generating antigen-presenting cells
10/12/2006	US20060228335 Rhesus carcino embryonic antigen, nucleotides encoding same, and uses thereof
10/12/2006	US20060228333 Methods for control of tumors and chronic infections by modulating immunologically informed carriers homing to tolerogenic organs or tissues
10/12/2006	US20060228329 Homogeneous preparations of IL-31
10/12/2006	US20060228328 Immunogenic acute phase protein-antigenic molecule complexes and fusion proteins
10/12/2006	US20060228326 Active specific immunotherapy of cancer metastasis
10/12/2006	US20060228306 Combination antihistamine and steroid medication
10/12/2006	US20060228300 Fusion propteins; homogeneous purity, and unaltered affinity, and can be produced in high yields without the requirement of extensive purification; stable in serum to allow in vivo applications
10/12/2006	US20060228299 Constructs binding to phosphatidylserine and their use in disease treatment
10/12/2006	CA2604855A1 Ehrlichia canis diva (differentiate infected from vaccinated animals)
10/12/2006	CA2604494A1 Improved method and apparatus for treating bacterial infections in devices
10/12/2006	CA2604488A1 Formulations and process for production of bordetella bronchiseptica p68 antigen and vaccines
10/12/2006	CA2604034A1 Improved stably tethered structures of defined compositions with multiple functions or binding specificities
10/12/2006	CA2604032A1 Methods for generating stably linked complexes composed of homodimers, homotetramers or dimers of dimers and uses
10/12/2006	CA2603805A1 Use of rip in treating staphylococcus aureus infections
10/12/2006	CA2603662A1 Combination consisting of a histological or cytological fixing solution and of one or more photoactivatable compounds of the family of quinones, in particular, hypericin, hypocrellin a and hyprcrellin b
10/12/2006	CA2603480A1 Use of an antibody against the laminin receptor or laminin receptor precursor for the treatment or diagnosis of several cancer types
10/12/2006	CA2603408A1 Process for production of polypeptide by regulation of assembly
10/12/2006	CA2602732A1 Methods to measure immunosuppressive tacrolimus, sirolimus, and cyclosporin a complexes in a blood sample
10/12/2006	CA2602090A1 Bioactive stents for type ii diabetics and methods for use thereof
10/12/2006	CA2601705A1 Use of wnv dna vaccine in combination with a conventional vaccine to overcome immunogen interference
10/11/2006	EP1710582A2 Suppressor genes
10/11/2006	EP1710314A1 Humanized immunoglobulin reactive with alpha4beta7 integrin
10/11/2006	EP1710311A2 Antigenic polypeptides
10/11/2006	EP1710309A2 Use of gene ncsag4 for the diagnosis and prevention of neosporosis and as a marker for analysis of the pathogenesis
10/11/2006	EP1710301A1 L-gulonolactone dehydrogenase of Mycobacterium tuberculosis
10/11/2006	EP1710300A1 Highly safe smallpox vaccine virus and vaccinia virus vector
10/11/2006	EP1710256A1 Human monoclonal antibodies to prostate specific membrane antigen
10/11/2006	EP1710254A2 Inhibitors of vascular endothelial growth factor activity, their uses and processes for their production
10/11/2006	EP1710252A2 Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof
10/11/2006	EP1709972A1 Use of an antibody against the laminin receptor or laminin receptor precursor for the treatment or diagnosis of several cancer types
10/11/2006	EP1709971A1 Peptide antigens useful for the prophylaxis, treatment and diagnosis of poxvirus infections
10/11/2006	EP1709970A1 Human antibodies against EGFR, derived from immunized xenomice
10/11/2006	EP1709177A2 Dna-sequence and recombinant production of group 4 major allergens from cereals
10/11/2006	EP1709162A2 A novel process of hepatitis a vaccine preparation
10/11/2006	EP1709150A2 Use of notch pathway interfering agents for treatment of plasma cell disorders
10/11/2006	EP1709080A2 ANTIBODIES TO MAdCAM
10/11/2006	EP1709079A2 Compositions and methods for treating t-cell mediated autoimmune diseases
10/11/2006	EP1709077A1 Process for the manufacture of virus safe immunoglobulin
10/11/2006	EP1709073A2 SUBSTANCE BINDING HUMAN IgG Fc RECEPTOR IIb (FcgammaRIIb)
10/11/2006	EP1709070A1 Peptides for treatment of autoimmune diseases
10/11/2006	EP1709067A2 Lawsonia intracellularis subunit vaccines
10/11/2006	EP1709064A2 Dna sequence, and recombinant production of the grass pollen allergen lol p 4
10/11/2006	EP1708961A2 Treatment of inflammatory bowel diseases with anti-ip-10 antibodies
10/11/2006	EP1708753A1 Use of goat serum for veterinary treatment
10/11/2006	EP1708752A2 Polymer-bound antibody cancer therapeutic agent
10/11/2006	EP1708751A2 Methods of killing tumor cells by targeting internal antigens exposed on apoptotic tumor cells
10/11/2006	EP1708750A1 Targeting of erb antigens
10/11/2006	EP1708749A1 Mucosal vaccine adjuvants containing bacterial flegellins as an active component
10/11/2006	EP1708748A2 Influenza immunogen and vaccine
10/11/2006	EP1708747A2 Non-animal origin stabilizers and processes for producing the same
10/11/2006	EP1708746A2 Recombinant vaccine against japanese encephalitis virus [jev] infection and a method thereof
10/11/2006	EP1708745A1 Antibodies for oncogenic strains of hpv and methods of their use
10/11/2006	EP1708744A2 Gm1 binding deficient exotoxins for use as immunoadjuvants
10/11/2006	EP1708743A1 PASSIVE IMMUNIZATION AGAINST i CLOSTRIDIUM DIFFICILE /i DISEASE
10/11/2006	EP1708742A2 Methods of enhancing immune response in the intradermal compartment and compounds useful thereof
10/11/2006	EP1708741A2 Recombinant nucleic acid molecules encoding fusion proteins comprising antigens and bacterial secretory signal polypeptides, expression cassettes, and bacteria, and methods of use thereof
10/11/2006	EP1708732A2 Synthetic hla binding peptide analogues and uses thereof
10/11/2006	EP1210374B1 Human monoclonal antibodies to prostate specific membrane antigen
10/11/2006	EP1154827B1 Purification of biological substances
10/11/2006	EP1154792B1 Tuberculosis vaccine formulation comprising monoglycerides or fatty acids as adjuvant
10/11/2006	EP1140149B1 Use of human growth hormone to increase the number of circulating cd34+ cells, intended for reconstitution of the hematopoietic and immune systems following myeloablative or antiblastic therapies, by transplantation, re-infusion or engraftment
10/11/2006	EP1133311B1 INFLUENCING ANGIOGENESIS USING CD66a
10/11/2006	EP1107959B1 Quinazoline derivatives as medicaments
10/11/2006	EP1092767B1 Serine protease-specific monoclonal antibody and utilization thereof
10/11/2006	EP0968230B1 Oxidized fragments of apolipoprotein b and their use
10/11/2006	EP0914448B1 Lipid kinase
10/11/2006	EP0896586B1 ErbB3 ANTIBODIES
10/11/2006	EP0832225B1 Chimeric proteins for use in transport of a selected substance into cells
10/11/2006	EP0751782B1 Use of a non-neutralizing antibody specific for the beta-subunit of luteinizing hormone for enhancing fertility
10/11/2006	EP0668777B1 Prostate-specific membrane antigen
10/11/2006	EP0490972B2 Recombinant negative strand rna virus expression systems and vaccines
10/11/2006	CN1845995A Chimeric antigens for breaking host tolerance to foreign antigens
10/11/2006	CN1845988A Method for immunotherapy of tumors
10/11/2006	CN1845936A Ra antigenic peptides
10/11/2006	CN1845756A Methods and compositions for treating herpes infections
10/11/2006	CN1845755A Anti-CD20 therapy of ocular disorders
10/11/2006	CN1845754A Vaccine composition for vaccinating dogs against canine infectious respiratory disease (CIRD)
10/11/2006	CN1844376A Recombinant herpes simplex virus type 2 and its preparing method and use
10/11/2006	CN1844151A Monoclonal antibody against human CD40 mutant molecule and its use
10/11/2006	CN1844148A Preparation and use of monoclonal antibody against human GL50
10/11/2006	CN1844146A Monoclonal antibody against human B7-1 molecule and its use
10/11/2006	CN1843510A Preparation method and medicinal uses of Trichinella eelworm vaccine
10/11/2006	CN1843509A Freeze-drying hepatitis A attenuated live vaccine and its preparation method
10/11/2006	CN1843507A Mumps virus ingredient vaccine for human, and its preparation method and uses
10/11/2006	CN1843506A Medicine containing bacillus tubercle vaccine
10/11/2006	CN1279168C Method for obtaining modified immunoglobulins with reduced immunogenicity of murine antibody variable domains and compositions containing them
10/11/2006	CN1279165C Inflenza vaccine composition
10/11/2006	CN1279058C Engineering antibody against CD44 for inducing leukemia cell differentiation and necrosis, its carrier and use
10/11/2006	CN1279057C Recombined anti-CD25 monoclonal antibody, coding sequence and application
10/11/2006	CN1279056C Specific antibody of tumor-associated antigen SM5-1 and use thereof
10/11/2006	CN1279054C Type I cytokine receptor TCCR
10/11/2006	CN1278739C Medicine box containing anti human spermatine single chain antibody/human carboxypeptidase A fusion protein and precursor medicine
10/11/2006	CN1278738C Mucous membrane immunizing agent of polyglycol-inactivated vaccine
10/11/2006	CN1278635C Biological agent for reducing specific nitrosamine content which tobacco has, preparation method and use
10/10/2006	US7119248 Antibodies against epitopes with homology to self antigens, methods of preparation and applications thereof
10/10/2006	US7119181 Nucleic acids and expression vectors; genetic engineering; diagnosis and detection of DNA, RNA or antibodies of the lymphadenopathy retrovirus
10/10/2006	US7119174 AURORA-1/2 (AUR1/2) antibodies or fragments thereof; humanized monoclonal antibodies; hybridomas; immunoassay; for treatment of cancer and screening cell growth inhibitors
10/10/2006	US7119172 Monoclonal antibodies for treating or diagnosing Pseudomonas aeruginosa (P. aeruginosa) infections and related disorders (e.g., cystic fibrosis)

1 ... 924 925 926 927 928 929 930 931 932 933 934 935 936 937 938 939 940 941 942 943 944 ... 1823